Detalhe da pesquisa
1.
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.
N Engl J Med
; 387(4): 310-320, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830649
2.
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Blood
; 141(16): 1971-1981, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626583
3.
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
Ann Hematol
; 103(6): 1989-2001, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233570
4.
Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis.
Ann Hematol
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267559
5.
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Am J Gastroenterol
; 118(8): 1373-1380, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36728217
6.
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Haematologica
; 108(3): 811-821, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200417
7.
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
Ann Hematol
; 102(8): 2233-2240, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392367
8.
Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8+ T Cell Responses.
Int J Mol Sci
; 24(18)2023 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37761976
9.
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
Ann Hematol
; 100(8): 2051-2059, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33447888
10.
Comparison of spectra optia and amicus cell separators for autologous peripheral blood stem cell collection.
J Clin Apher
; 36(1): 28-33, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32882095
11.
Analysis of laboratory parameters for optimal autologous peripheral blood stem cell collection from lymphoma and myeloma patients.
J Clin Apher
; 36(1): 135-142, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33247855
12.
Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies.
J Korean Med Sci
; 36(13): e85, 2021 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821592
13.
Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation.
J Korean Med Sci
; 36(8): e55, 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650334
14.
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report.
Ann Hematol
; 99(2): 223-228, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31853704
15.
Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
Ann Hematol
; 99(1): 213, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844930
16.
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
Ann Hematol
; 99(2): 255-264, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31897676
17.
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
Ann Hematol
; 99(2): 309-319, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872360
18.
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).
Am J Hematol
; 95(4): 413-421, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919872
19.
Analysis of factors associated with successful allogeneic peripheral blood stem cell collection in healthy donors.
Transfus Apher Sci
; 59(2): 102679, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31831328
20.
A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study.
Biol Blood Marrow Transplant
; 25(7): 1312-1319, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910603